FDA Approves Venetoclax for Chronic Lymphocytic Leukemia With 17p Deletion

FDA Approves Venetoclax for Chronic Lymphocytic Leukemia With 17p Deletion

www.fda.gov/newsevents/newsroom/pressannouncements/ucm495253.htm

More News